LIFR and breast carcinoma: Interestingly, LIF receptor/STAT3 signaling is proved to be a dormancy phenotype to disseminated breast cancer cells, and inactivation of JAK/STAT pathway might contribute to disease progression and metastasis (Johnson et al., 2016).